Research makes strong case for broader use of GLP1 drugs to protect hearts

The Medical News · 2h ago

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) makes a case for extending the indication for GLP1- receptor agonists (GLP1-RAs) to millions more people, to protect their heart health.

Read original article on The Medical News →

Research makes strong case for broader use of GLP1 drugs to protect hearts

Related news